Replies to post #811345 on NorthWest Biotherapeutics Inc (NWBO)

[Zadie420]

Agree Gary. I don't understand LSE trading impact on OTC trading. Is there something there I am missing?

[GoodGuyBill]

"People are making entirely too much importance on the London Stock Exchange."

I disagree for the following reason presented in my post. Wall street has captured the stock market and NWBO has done everything within the system to break itself free. The LSE may be the easiest, cost-effective way to screw the money makers.

4. The strategic payoff of reactivation is enormous
If NWBO activates 0K95 and admits to LSE trading, several powerful forces come into play:

A. FCA + MAR enforcement pressure
The FCA has a strong record of prosecuting:
?spoofing
?layering
?false liquidity
?manipulative order strategies

Replicating U.S. suppression behavior on LSE becomes far riskier.

B. Cross-venue arbitrage breaks containment
Once NWBO trades on both LSE and U.S. OTC:
?arbitrage bots link prices
?LSE price becomes a second anchor
?suppression on one venue becomes harder
?synthetic positions become more expensive to maintain

C. The compliance trap
Market makers face a binary choice If OK95 is reactivated:
?Replicate U.S. behavior on LSE
* high regulatory risk
* cross-border evidence
* potential FCA enforcement
?Dial back behavior on LSE
* more honest price discovery
* upward pressure on the entire complex
Either path increases pressure on synthetic exposure.

D. Litigation leverage increases
If NWBO activates LSE trading:
?defendants’ behavior becomes observable in a stricter jurisdiction
?any manipulation becomes more discoverable
?-settlement pressure increases-
?NWBO gains a forward-looking enforcement mechanism
?-This is the first move NWBO could make that changes the ongoing economics of suppression.